Skip to content

Clinical trials

Phase 1/2 Rectal Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Rectal Neoplasms Phase: Phase 1/2 Clear all

108 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20007
20015
20023
20031
20044
20053
20062
20074
20085
20093
20103
20114
20124
20134
20141
20152
20165
20174
20182
20196
20206
20222
20236
20246
20253
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed51
Terminated16
Recruiting14
Unknown status13
Active, not recruiting6
Withdrawn5
Not yet recruiting2
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)11
M.D. Anderson Cancer Center5
Roswell Park Cancer Institute4
Gilead Sciences3
Memorial Sloan Kettering Cancer Center3
Swiss Cancer Institute3
A2 Biotherapeutics Inc.2
Amgen2
Chongqing Precision Biotech Co., Ltd2
City of Hope Medical Center2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Rectal Neoplasms108
Colonic Neoplasms71
Colorectal Neoplasms57
Pancreatic Neoplasms18
Neoplasms10
Neoplasm Metastasis9
Stomach Neoplasms9
Breast Neoplasms8
Carcinoma, Non-Small-Cell Lung8
Ovarian Neoplasms8

Trials

Showing 26 to 50 of 108. Each trial links to its page on Pharma Observatory.

8 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.